In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Prima Biomed's Phase II cancer vaccine to be manufactured by Progen
New Australian collaboration to develop world's first Alzheimer's vaccine
Nexell receives genetic modification patent
Antigenics receives heat shock protein patent
Epimmune receives patent for vaccine technology
Milkhaus granted antibody patent
U.S. Patent and Trademark Office issues cancer vaccine patent
SIBIA Alzheimer's disease patent issued in US
Antex receives Helicobacter Pylori patent
Australian Cancer Technology announces its intention to acquire US cancer care business
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
